The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Gilead Sciences, Inc.

Johnson & Johnson

Pfizer Inc.

Amgen Inc.

AbbVie Inc.

Merck & Co., Inc.

Abbott Laboratories

Eli Lilly and Company

Tarsus Pharmaceuticals, Inc.

Harmony Biosciences Holdings, Inc.

Healthcare

Invesco Pharmaceuticals ETF

PJP Holdings & Sector Breakdown